
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7555672
[patent_doc_number] => 08067573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Nucleic acid agents for downregulating H19 and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 11/994810
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 21
[patent_no_of_words] => 15722
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067573.pdf
[firstpage_image] =>[orig_patent_app_number] => 11994810
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/994810 | Nucleic acid agents for downregulating H19 and methods of using same | Jul 5, 2006 | Issued |
Array
(
[id] => 5374838
[patent_doc_number] => 20090312399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'GUANOSINE-RICH OLIGONUCLEOTIDES AS AGENTS FOR INDUCING CELL DEATH IN EUKARYOTIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/993537
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25245
[patent_no_of_claims] => 121
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312399.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993537
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993537 | GUANOSINE-RICH OLIGONUCLEOTIDES AS AGENTS FOR INDUCING CELL DEATH IN EUKARYOTIC CELLS | Jun 27, 2006 | Abandoned |
Array
(
[id] => 5166091
[patent_doc_number] => 20070287678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'ANTI-AGING MICRORNAS'
[patent_app_type] => utility
[patent_app_number] => 11/426292
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20051
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20070287678.pdf
[firstpage_image] =>[orig_patent_app_number] => 11426292
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/426292 | Anti-aging micrornas | Jun 22, 2006 | Issued |
Array
(
[id] => 5242870
[patent_doc_number] => 20070021365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto'
[patent_app_type] => utility
[patent_app_number] => 11/471033
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21210
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471033
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471033 | Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto | Jun 19, 2006 | Abandoned |
Array
(
[id] => 5355471
[patent_doc_number] => 20090186815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE RNAI SCREENING'
[patent_app_type] => utility
[patent_app_number] => 11/917653
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20605
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186815.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917653
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917653 | IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE RNAI SCREENING | Jun 13, 2006 | Abandoned |
Array
(
[id] => 62971
[patent_doc_number] => 07763592
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-07-27
[patent_title] => 'SHIP-deficiency to increase megakaryocyte progenitor production'
[patent_app_type] => utility
[patent_app_number] => 11/451004
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 27649
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/763/07763592.pdf
[firstpage_image] =>[orig_patent_app_number] => 11451004
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/451004 | SHIP-deficiency to increase megakaryocyte progenitor production | Jun 11, 2006 | Issued |
Array
(
[id] => 5392316
[patent_doc_number] => 20090209629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications'
[patent_app_type] => utility
[patent_app_number] => 11/917680
[patent_app_country] => US
[patent_app_date] => 2006-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 22064
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209629.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917680
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917680 | Nucleic acid functionalized nanoparticles for therapeutic applications | Jun 7, 2006 | Issued |
Array
(
[id] => 5700063
[patent_doc_number] => 20060216747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 11/448115
[patent_app_country] => US
[patent_app_date] => 2006-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 60967
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216747.pdf
[firstpage_image] =>[orig_patent_app_number] => 11448115
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/448115 | RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA) | Jun 5, 2006 | Abandoned |
Array
(
[id] => 6499877
[patent_doc_number] => 20100286228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Method of inhibiting intimal hyperplasia'
[patent_app_type] => utility
[patent_app_number] => 11/921084
[patent_app_country] => US
[patent_app_date] => 2006-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7040
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286228.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921084
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921084 | Method of inhibiting intimal hyperplasia | May 31, 2006 | Abandoned |
Array
(
[id] => 5142445
[patent_doc_number] => 20070004661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Antisense antiviral compound and method for treating influenza viral infection'
[patent_app_type] => utility
[patent_app_number] => 11/433213
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14643
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004661.pdf
[firstpage_image] =>[orig_patent_app_number] => 11433213
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/433213 | Antisense antiviral compound and method for treating influenza viral infection | May 10, 2006 | Abandoned |
Array
(
[id] => 5733492
[patent_doc_number] => 20060258609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Method for inhibition of lipogenesis by regulating PRP19 expression'
[patent_app_type] => utility
[patent_app_number] => 11/430131
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3227
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258609.pdf
[firstpage_image] =>[orig_patent_app_number] => 11430131
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/430131 | Method for inhibition of lipogenesis by regulating PRP19 expression | May 8, 2006 | Abandoned |
Array
(
[id] => 191036
[patent_doc_number] => 07642348
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-05
[patent_title] => 'Prostate cancer-related nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 11/429720
[patent_app_country] => US
[patent_app_date] => 2006-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11519
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/642/07642348.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429720
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429720 | Prostate cancer-related nucleic acids | May 7, 2006 | Issued |
Array
(
[id] => 5193498
[patent_doc_number] => 20070081982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Multiple RNAi expression cassettes for simultaneous delivery of RNAi agents related to heterozygotic expression patterns'
[patent_app_type] => utility
[patent_app_number] => 11/413628
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10889
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20070081982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413628
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413628 | Multiple RNAi expression cassettes for simultaneous delivery of RNAi agents related to heterozygotic expression patterns | Apr 27, 2006 | Abandoned |
Array
(
[id] => 5374971
[patent_doc_number] => 20090312532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secodary rna structure'
[patent_app_type] => utility
[patent_app_number] => 11/919248
[patent_app_country] => US
[patent_app_date] => 2006-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13062
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312532.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919248
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919248 | Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secodary rna structure | Apr 20, 2006 | Abandoned |
Array
(
[id] => 6496302
[patent_doc_number] => 20100010064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Cancer treatment by combined inhibition of proteasome and telomerase activities'
[patent_app_type] => utility
[patent_app_number] => 11/918581
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11192
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20100010064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918581
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918581 | Cancer treatment by combined inhibition of proteasome and telomerase activities | Apr 13, 2006 | Issued |
Array
(
[id] => 5515555
[patent_doc_number] => 20090215862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Micro rna'
[patent_app_type] => utility
[patent_app_number] => 11/918459
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10419
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215862.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918459
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918459 | Micro rna | Apr 11, 2006 | Abandoned |
Array
(
[id] => 8469862
[patent_doc_number] => 08299041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-30
[patent_title] => 'Compositions and their uses directed to acetyl-CoA carboxylases'
[patent_app_type] => utility
[patent_app_number] => 11/910606
[patent_app_country] => US
[patent_app_date] => 2006-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17754
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910606
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910606 | Compositions and their uses directed to acetyl-CoA carboxylases | Apr 9, 2006 | Issued |
Array
(
[id] => 7663747
[patent_doc_number] => 20110313016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'Treatment of Intestinal Conditions'
[patent_app_type] => utility
[patent_app_number] => 11/908696
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10359
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20110313016.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908696 | Treatment of Intestinal Conditions | Mar 13, 2006 | Abandoned |
Array
(
[id] => 5700660
[patent_doc_number] => 20060217345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Beta-L-nucleosides and use thereof as pharmaceutical agents for the treatment of viral diseases'
[patent_app_type] => utility
[patent_app_number] => 11/373062
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17483
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217345.pdf
[firstpage_image] =>[orig_patent_app_number] => 11373062
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/373062 | Beta-L-nucleosides and use thereof as pharmaceutical agents for the treatment of viral diseases | Mar 9, 2006 | Abandoned |
Array
(
[id] => 5304088
[patent_doc_number] => 20090298740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'NOVEL NUCLEOTIDE SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 11/817252
[patent_app_country] => US
[patent_app_date] => 2006-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3134
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298740.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817252
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817252 | Nucleotide sequences | Mar 1, 2006 | Issued |